Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q1 2024 · 10-Q
Revenue$977.65K$977.65K+753.3% vs Q1 2023 Net Income-$3.34M-$3.34MN/M vs Q1 2023 EPS Diluted-$0.14-$0.14N/M vs Q1 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flow-$3,809,391N/M Free Cash Flowderived-$3,846,522N/M Margins · derivedGross margin27.2%+38.0 pt vs Q1 2023
Operating margin-346.8%+1210.5 pt vs Q1 2023
Net margin-342.1%+1170.2 pt vs Q1 2023
ended Dec 31, 2023 · filed Feb 13, 2024 · 44 d after period end